FDA NDC Directory · JSON-LD · Markdown
NDC 65862-942 · HUMAN PRESCRIPTION DRUG · SOLUTION, CONCENTRATE
| Labeler / Manufacturer | Aurobindo Pharma Limited |
|---|---|
| Marketing category | Abbreviated NDA (generic) · App ANDA207628 |
| Dosage form / route | SOLUTION, CONCENTRATE · RESPIRATORY (INHALATION) |
| Active ingredients | LEVALBUTEROL HYDROCHLORIDE (1.25 mg/.5mL) |
| Marketing started | 20170131 |
| Package count | 1 |
Source: openFDA. Public-domain (CC0).